Stock Markets June 2, 2026 05:12 AM

Philip Morris trims 2026 adjusted EPS outlook; shares drop in premarket trading

Company flags a roughly $500 million non-cash impairment on RBH and updates EPS ranges to reflect currency and the charge

By Caleb Monroe PM

Philip Morris International cut its 2026 adjusted earnings-per-share guidance and warned of a roughly $500 million non-cash impairment tied to RBH, prompting about a 1% decline in premarket trading on Tuesday. The company also revised reported and quarterly EPS ranges to account for currency impacts and the impairment, while noting an expected adjusted EPS growth rate versus 2025 when certain adjustments are excluded.

Philip Morris trims 2026 adjusted EPS outlook; shares drop in premarket trading
PM

Key Points

  • Philip Morris trimmed its 2026 adjusted diluted EPS guidance to $8.31 - $8.46 from $8.36 - $8.51.
  • The company plans to record an approximate $500 million non-cash impairment on RBH in Q2 2026, equal to $0.33 of diluted EPS, with RBH remaining deconsolidated and carrying value expected below $100 million.
  • Reported 2026 diluted EPS guidance was revised to $7.18 - $7.33 to reflect currency effects and the RBH impairment; Q2 adjusted EPS range is $1.97 - $2.02 and includes an estimated -$0.03 currency impact.

Philip Morris International (NYSE:PM) shares fell roughly 1% in premarket trading on Tuesday after the tobacco company reduced its full-year adjusted earnings-per-share guidance for 2026.

The company narrowed its adjusted diluted EPS forecast for 2026 to a range of $8.31 to $8.46, down from the prior guidance of $8.36 to $8.51. The new range sits near the Bloomberg consensus estimate of $8.41.

Philip Morris said it expects to recognize a non-cash impairment charge of about $500 million related to RBH in the second quarter of 2026. The company quantified that the charge will equate to 33 cents of diluted EPS. Philip Morris also noted that RBH remains deconsolidated from the group and that the remaining carrying value of RBH is expected to be under $100 million.

To incorporate currency impacts and the non-cash RBH impairment, the company updated its full-year 2026 reported diluted EPS outlook to a range of $7.18 to $7.33. Separately, Philip Morris adjusted its second-quarter adjusted diluted EPS outlook for currency to a range of $1.97 to $2.02, stating that this figure includes an estimated unfavorable currency impact of 3 cents at prevailing exchange rates.


Adjusted-growth context

Philip Morris highlighted how the adjusted outlook translates versus last year after excluding expected adjustments. The company indicated that, excluding a total 2026 adjustment of $1.13 per share, the adjusted diluted EPS forecast range implies a projected increase of 10.2% to 12.2% compared with $7.54 in 2025.


Key implications

  • Near-term equity reaction: Shares slipped about 1% in premarket trading following the guidance cut and impairment announcement.
  • Financial reporting: The company revised both reported and adjusted EPS ranges for 2026, and updated its Q2 adjusted EPS range to reflect currency headwinds.
  • Balance-sheet note: RBH is deconsolidated with a remaining carrying value expected to be below $100 million after a roughly $500 million non-cash impairment in Q2 2026.

Summary of figures provided by the company

  • 2026 adjusted diluted EPS forecast: $8.31 - $8.46 (previously $8.36 - $8.51).
  • Bloomberg consensus for 2026 adjusted EPS: $8.41.
  • Anticipated non-cash RBH impairment: approximately $500 million, representing $0.33 of diluted EPS in Q2 2026.
  • 2026 reported diluted EPS forecast (post-impairment and currency): $7.18 - $7.33.
  • Q2 adjusted diluted EPS forecast (currency-adjusted): $1.97 - $2.02, including an estimated -$0.03 currency impact at prevailing rates.
  • Excluding total 2026 adjustments of $1.13 per share, projected adjusted EPS growth for 2026: 10.2% - 12.2% versus $7.54 in 2025.

Context and limitations

The company’s updated guidance and the one-time accounting charge provide the basis for the market move reported in premarket trading. The outlook and figures above reflect the ranges and estimates stated by the company; where the company references estimated currency impacts or expected carrying values, those remain subject to the company’s own assumptions and subsequent reporting.

Risks

  • Currency fluctuations are explicitly cited as an unfavorable influence on quarterly and full-year adjusted EPS, which may affect reported results and investor expectations - impacting multinational consumer staples and equity valuations.
  • The planned non-cash impairment tied to RBH could reduce reported earnings and alter balance-sheet carrying values, introducing uncertainty for accounting and investor assessment within tobacco and consumer packaged goods sectors.
  • RBH remains deconsolidated and its residual carrying value is expected to be under $100 million, creating uncertainty around future recoveries or write-downs that could influence reported results.

More from Stock Markets

Meta Shares Slide After Reports of Possible Multibillion-Dollar Equity Offer Jun 5, 2026 Mixed Market Movers: Chip, Cloud, Casino and Homebuilder Stocks Lead This Week's Volatility Jun 5, 2026 Cai Qi Elevated to Lead Central Party School, Consolidating Key Party Functions Jun 5, 2026 Broad Market Slide Sees Arm, Marvell and Several Tech Names Lead Declines Jun 5, 2026 Quiet Monday on U.S. data calendar as Employment Trends Index takes center stage Jun 5, 2026